Tolevamer is an investigational drug.
There have been 4 clinical trials for Tolevamer.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Enterocolitis, Pseudomembranous, Diarrhea, and Enterocolitis. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].